Matthew Taylor

Matthew Taylor is a results-driven Scientist III at Genentech, coordinating analytical ligand binding assays for clinical studies and ensuring compliance with FDA guidelines. Previously, they served as a Senior Research Associate at Medgenome, focusing on antibody production and advanced purification techniques. Their earlier experience includes roles as a Research Associate at Vanguard Therapeutics Inc. and BioMarin Nederland B.V., where they developed pharmacokinetic assays and performed quantitative analyses. Matthew holds a BS in Physiology from San Francisco State University and completed a Bridge to Bioscience program at City College of San Francisco.